ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q4 2025 Earnings Call Transcript
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q4 2025 Earnings Call Transcript February 27, 2026ALX Oncology Holdings Inc. misses on earnings expectations.
Alx Oncology Holdings Inc (ALXO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 3,264,718 | $3,689,131 | -3% | 0.27% |
| 2. | Millennium Management Israel Englander | 3,204,619 | $3,621,219 | +23% | 0% |
| 3. | Almitas Capital Ron Mass | 2,536,891 | $2,866,687 | 0.63% | |
| 4. | Driehaus Capital Richard Driehaus | 1,422,882 | $1,607,857 | +79% | 0.01% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 710,400 | $802,752 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.57 | 3,184,713 | $4,999,999.41 | 8,453,038 | 2026-02-02 | Filing | |
| $1.08 | 71,163 | $76,891.62 | 305,121 | 2025-09-17 | Filing | |
| $1.07 | 21,070 | $22,460.62 | 233,958 | 2025-09-16 | Filing | |
| $0.78 | 75,000 | $58,402.50 | 75,000 | 2025-08-18 | Filing | |
| $1.55 | 30,000 | $46,404.00 | 33,000 | 2024-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.17 | 12,311 | $26,714.87 | 293,609 | 2026-03-19 | Filing | |
| $2.17 | 903 | $1,959.51 | 86,805 | 2026-03-19 | Filing | |
| $2.27 | 565 | $1,282.55 | 87,708 | 2026-02-18 | Filing | |
| $1.11 | 3,925 | $4,356.75 | 88,273 | 2026-01-06 | Filing | |
| $0.64 | 611 | $391.28 | 89,198 | 2025-08-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,179,736 | $8,380,371 | 0% | |
| 2. | 914,754 | $1,834,082 | 0% | |
| 3. | 294,478 | $590,428 | 0% | |
| 4. | 97,881 | $196,251 | 0% | |
| 5. | 37,997 | $74,854 | 0% |
News See All
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q3 2025 Earnings Call Transcript
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q3 2025 Earnings Call Transcript November 7, 2025ALX Oncology Holdings Inc. misses on earnings expectations.
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q2 2025 Earnings Call Transcript
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q2 2025 Earnings Call Transcript August 12, 2025ALX Oncology Holdings Inc. misses on earnings expectations.
Hedge Fund and Insider Trading News: Kyle Bass, Alan Howard, Louis Bacon, IGM Biosciences Inc (IGMS), Seacor Holdings, Inc. (CKH), and More
Kyle Bass, Hayman Capital Management chief investment officer, joined “Squawk Box” on Wednesday to discuss what he thinks may be the biggest issues President-elect Joe Biden when it comes to U.S.-...
Is ALXO A Good Stock To Buy Now?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffet, Point72 Asset Management, Farallon Capital Management, Optima Asset Management, ALX Oncology Holdings Inc (ALXO), VMware, Inc. (VMW), and More
Billionaire investor Bill Ackman told CNBC on Wednesday he’s bullish on the U.S.